The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response
Open accessAbstract
The reasons for hepatitis C treatment failure remain unknown but may be related to different host responses to therapy. In this study, we compared hepatic gene expression in patients prior to and during peginterferon and ribavirin therapy. In the on-treatment group, patients received either ribavirin for 72 hours prior to peginterferon alpha-2a injection or peginterferon alpha-2a for 24 hours, prior to biopsy. The patients were grouped into rapid responders (RRs) with a greater than 2-log drop and slow responders (SRs) with a less than 2-log drop in hepatitis C virus RNA by week 4. Pretreatment biopsy specimens were obtained from a matched control group. The pretreatment patients were grouped as RRs or SRs on the basis of the subsequent treatment response. Gene expression profiling was performed with Affymetrix microarray technology. Known interferon-stimulated genes (ISGs) were induced in treated patients. In the pretreatment group, future SRs had higher pretreatment ISG expression than RRs. On treatment, RRs and SRs had similar absolute ISG expression, but when it was corrected for the baseline expression with the pretreatment group, RRs showed a greater fold change in ISGs, whereas SRs showed a greater change in interferon (IFN)-inhibitory pathways. The patients pretreated with ribavirin had heightened induction of IFN-related genes and down-regulation of genes involved in IFN inhibition and hepatic stellate cell activation. Conclusion: These data suggest that ISG inducibility is important for the treatment response and that ribavirin may improve outcomes by enhancing hepatic gene responses to peginterferon. Collectively, these mechanisms may provide a molecular basis for the improved efficacy of combination therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Self-citationManns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Mechanism of action of interferon and ribavirin in treatment of hepatitis C
Feld, J. J., & Hoofnagle, J. H. (2005) · Nature · doi:10.1038/nature04082 · Cited by 992
Self-citationPeginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis
Heathcote, E. J., Shiffman, M. L., Cooksley, W. G. E., Dusheiko, G. M., Lee, S. S., Balart, L., Reindollar, R., Reddy, R. K., Wright, T. L., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432302 · Cited by 874
Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease
Foy, E., Li, K., Wang, C., Sumpter, R., Ikeda, M., Lemon, S. M., & Gale, M. (2003) · Science · doi:10.1126/science.1082604 · Cited by 788
Conjeevaram, H. S., Fried, M. W., Jeffers, L. J., Terrault, N. A., Wiley–Lucas, T. E., Afdhal, N., Brown, R. S., Belle, S. H., Hoofnagle, J. H., Kleiner, D. E., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.06.008 · Cited by 472
Self-citationChen, L., Borozan, I., Feld, J., Sun, J., Tannis, L.-L., Coltescu, C., Heathcote, J., Edwards, A. M., & McGilvray, I. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.059 · Cited by 453
Self-citationMechanism of action of ribavirin in the combination treatment of chronic HCV infection
Lau, J. Y. N., Tam, R. C., Liang, J. T., & Hong, Z. (2002) · Hepatology · doi:10.1053/jhep.2002.32672 · Cited by 337
Self-citationHelbig, K. J., Lau, D. T.-Y., Semendric, L., Harley, H. A. J., & Beard, M. R. (2005) · Hepatology · doi:10.1002/hep.20844 · Cited by 231
Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A
Duong, F. H. T., Filipowicz, M., Tripodi, M., La Monica, N., & Heim, M. H. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.076 · Cited by 222
Lagging, M., Romero, A. I., Westin, J., Norkrans, G., Dhillon, A. P., Pawlotsky, J.-M., Zeuzem, S., von Wagner, M., Negro, F., Schalm, S. W., et al. (2006) · Hepatology · doi:10.1002/hep.21407 · Cited by 216
Transcriptional regulation of hepatic stellate cell activation: Figure 1
Mann, D. A., & Smart, D. E. (2002) · Gut · doi:10.1136/gut.50.6.891 · Cited by 190
Randall, G., Chen, L., Panis, M., Fischer, A. K., Lindenbach, B. D., Sun, J., Heathcote, J., Rice, C. M., Edwards, A. M., & McGilvray, I. D. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.043 · Cited by 179
Moisés Diago, M., Castellano, G., García‐Samaniego, J., Pérez, C., Fernández, I., Romero, M., Iacono, O. L., & García-Monzón, C. (2005) · Gut · doi:10.1136/gut.2005.074062 · Cited by 148
Taylor, M. W., Tsukahara, T., Brodsky, L., Schaley, J. E., Sanda, C., Stephens, M. J., McClintick, J. N., Edenberg, H. J., Li, L., Tavis, J. E., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02640-06 · Cited by 122
Lanford, R. E., Guerra, B., Lee, H., Chavez, D., Brasky, K. M., & Bigger, C. B. (2006) · Hepatology · doi:10.1002/hep.21167 · Cited by 114
Zhang, Y., Jamaluddin, M., Wang, S., Tian, B., Garofalo, R. P., Casola, A., & Brasier, A. R. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.5933-5947.2003 · Cited by 109
SUMO-1 conjugation selectively modulates STAT1-mediated gene responses
Ungureanu, D., Vanhatupa, S., Grönholm, J., Palvimo, J. J., & Silvennoinen, O. (2005) · Blood · doi:10.1182/blood-2004-11-4514 · Cited by 106
Huang, Y., Feld, J. J., Sapp, R. K., Nanda, S., Lin, J.-H., Blatt, L. M., Fried, M. W., Murthy, K. K., & Liang, T. J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.11.045 · Cited by 98
Self-citationBrand, S., Zitzmann, K., Dambacher, J., Beigel, F., Olszak, T., Vlotides, G., Eichhorst, S. T., Göke, B., Diepolder, H. M., & Auernhammer, C. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.004 · Cited by 91
Global Effect of PEG-IFN- α and Ribavirin on Gene Expression in PBMC In Vitro
Taylor, M. W., Grosse, W. M., Schaley, J. E., Sanda, C., Wu, X., Chien, S.-C., Smith, F., Wu, T. G., Stephens, M. J., Ferris, M. W., et al. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/107999004322813354 · Cited by 84
Everson, G. T., Jensen, D. M., Craig, J. R., van Leeuwen, D. J., Bain, V. G., Ehrinpreis, M. N., Albert, D., Joh, T., & Witt, K. (1999) · Hepatology · doi:10.1002/hep.510300116 · Cited by 63
Transcriptional Regulation in Hepatic Stellate Cells
Eng, F. J., & Friedman, S. L. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17553 · Cited by 44
Analysis of Affymetrix GeneChip® Data Using Amplified RNA
Cope, L., Hartman, S. M., Göhlmann, H. W. H., Tiesman, J. P., & Irizarry, R. A. (2006) · BioTechniques · doi:10.2144/000112057 · Cited by 23
Bleicher, K. B., Pippert, T. R., Glaab, W. E., Skopek, T. R., Sina, J. F., & Umbenhauer, D. R. (2001) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10 · Cited by 23
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lindow, M., Munk, M. E., Kauppinen, S., & Ørum, H. (2010) · Science · doi:10.1126/science.1178178 · Cited by 1,459
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Hézode, C., Forestier, N., Dusheiko, G., Ferenci, P., Pol, S., Goeser, T., Bronowicki, J.-P., Bourlière, M., Gharakhanian, S., Bengtsson, L., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807650 · Cited by 1,025
The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
Galon, J., Angell, H. K., Bedognetti, D., & Marincola, F. M. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.008 · Cited by 864
Current and Future Therapies for Hepatitis C Virus Infection
Liang, T. J., & Ghany, M. G. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1213651 · Cited by 490
Metadata
- Authors
- Feld, J. J., Nanda, S., Huang, Y., Chen, W., Cam, M., Pusek, S. N., Schweigler, L. M., Theodore, D., Zacks, S. L., Liang, J. T., & Fried, M. W.
- Venue
- Hepatology
- Published
- 2007-11
- Volume
- 46
- Issue
- 5
- Pages
- 1548-1563
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2063783484
- Cited by
- 265
- References
- 25
- FWCI
- 16.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.